Induction of murine neonatal tolerance against Graves' disease using recombinant adenovirus expressing the TSH receptor A-subunit

Endocrinology

Volumn 152, Issue 3, 2011, Pages 1165-1171

  Wu, Liping ^a   Xun, Liru ^a   Yang, Jing ^a   Xu, Li ^a   Tian, Zhufang ^a   Gao, Shan ^a   Zhang, Yu ^a   Hou, Peng ^a   Shi, Bingyin ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AD TSHR289; RECOMBINANT VACCINE; THYROTROPIN RECEPTOR; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; FEMALE; GRAVES DISEASE; HYPERPLASIA; HYPERTHYROIDISM; IMMUNOLOGICAL TOLERANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYROID FOLLICULAR HYPERPLASIA;

ADENOVIRIDAE; ANIMALS; ANTIBODIES; ANTIGENS, CD; FEMALE; GENE EXPRESSION REGULATION; GENETIC VECTORS; GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; GRAVES DISEASE; MALE; MICE; MICE, INBRED BALB C; SPLEEN; T-LYMPHOCYTES, REGULATORY; THYROXINE;

EID: 79951932283     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0737     Document Type: Article

References (24)

1. Chen CR, Pichurin P, Nagayama Y, Latrofa F, Rapoport B, McLachlan SM 2003 The thyrotropin receptor autoantigen in Graves' disease is the culprit as well as the victim. J Clin Invest 111:1897-1904 (Pubitemid 38057734)
2. Chazenbalk GD, Pichurin P, Chen CR, Latrofa F, Johnstone AP, McLachlan SM, Rapoport B 2002 Thyroid-stimulating auto-antibodies in Graves disease preferentially recognize the free A-subunit, not the thyrotropin holoreceptor. J Clin Invest 110:209-217 (Pubitemid 34787358)
3. Shimojo N, Kohno Y, Yamaguchi K-I, Kikuoka S-I, Hoshioka A, Niimi H, Hirai A, Tamura Y, Saito Y, Kohn LD, Tahara K 1996 Induction of Graves'-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proc. Natl Acad Sci USA 93:11074-11079 (Pubitemid 26333120)
4. Kaithamana S, Fan J, Osuga Y, Liang SG, Prabhakar BS 1999 Induction of experimental autoimmune Graves' disease in BALB/c mice. J Immunol 163:5157-5164 (Pubitemid 29501285)
5. Costagliola S, Many MC, Denef JF, Pohlenz J, Refetoff S, Vassart G 2000 Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease. J Clin Invest 105:803-811 (Pubitemid 30164119)
6. Nagayama Y, Kita-Furuyama M, Ando T, Nakao K, Mizuguchi H, Hayakawa T, Eguchi K, Niwa M 2002 A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor. J Immunol 168:2789-2794 (Pubitemid 34211657)
7. Pichurin PN, Pichurina O, Marians RC, Chen CR, Davies TF, Rapoport B, McLachlan SM 2004 Thyrotropin receptor knockout mice: studies on immunological tolerance to a major thyroid autoantigen. Endocrinology 145:1294-1301 (Pubitemid 38281012)
8. Misharin AV, Nagayama Y, Aliesky HA, Mizutori Y, Rapoport B, McLachlan SM 2009 Attenuation of induced hyperthyroidism in mice by pretreatment with thyrotropin receptor protein: deviation of thyroid-stimulating to nonfunctional antibodies. Endocrinology 150:3944-3952
9. Green AP, Huang JJ, Scott MO, Kierstead TD, Beaupré I, Gao GP, Wilson JM 2002 A new scalable method for the purification of recombinant adenovirus vectors. Hum Gene Ther 13:1921-1934 (Pubitemid 35341034)
10. Rees Smith B, McLachlan SM, Furmaniak J 1988 Autoantibodies to the thyrotropin receptor. Endocr Rev 9:106-121
11. Marodon G., Rocha B 1994 Activation and 'deletion' of self- reactive mature and immature T cells during ontogeny of Mls-1a: implications for neonatal tolerance induction. In Immunol 6:1899-1904
12. Sarzotti M, Robbins DS, Hoffman PM 1996 Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 271:1726-1728 (Pubitemid 26102820)
13. Klinman NR, Sigal NH, Metcalf ES, Pierce SK, Gearhart PJ 1977 The interplay of evolution and environment in B-Cell diversification. Cold Spring Harbor Symp Quant Biol 41:165-173
14. Barouch DH 2006 Rational design of gene-based vaccines. J Pathol 208:283-289 (Pubitemid 43126120)
15. Wickham TJ, Roelvink PW, Brough DE, Kovesdi I 1996 Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types. Nat Biotechnol 14:1570-1573 (Pubitemid 26365551)
16. Wickham TJ, Tzeng E, Shears 2nd LL, Roelvink PW, Li Y, Lee GM, Brough DE, Lizonova A, Kovesdi I 1997 Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J Virol 71:8221-8229 (Pubitemid 27446397)
17. Ichino M, Mor G, Conover J, Weiss WR, Takeno M, Ishii KJ, Klinman DM 1999 Factors associated with the development of neonatal tolerance after the administration of a plasmid DNA vaccine. J Immunol 162:3814-3818 (Pubitemid 29314758)
18. Kang HK, Michaels MA, Berner BR, Datta SK 2005 Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets. J Immunol 174:3247-3255 (Pubitemid 40354027)
19. Kang HK, Liu M, Datta SK 2007 Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells. J Immunol 178:7849-7858 (Pubitemid 46898057)
20. Sakaguchi S 2004 Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22:531-562 (Pubitemid 38680433)
21. Bacchetta R, Gregori S, Roncarolo MG 2005 CD4+ regulatory T cells: mechanisms of induction and effector function. Autoimmun. Rev 4:491-496 (Pubitemid 41415758)
22. Ziegler SF 2006 FOXP3: of mice and men. Annu Rev Immunol 24:209-226
23. Han G, Li Y, Wang J, Wang R, Chen G, Song L, Xu R, Yu M, Wu X, Qian J, Shen B 2005 Active tolerance induction and prevention of autoimmune diabetes by immunogene therapy using recombinant adenoassociated virus expressing glutamic acid decarboxylase 65 peptide GAD(500-585). J Immunol 174:4516-4524
24. Song X, Liang F, Liu N, Luo Y, Xue H, Yuan F, Tan L, Sun Y, Xi C, Xi Y 2009 Construction and characterization of a novel DNA vaccine that is potent antigen-specific tolerizing therapy for experimental arthritis by increasing CD4+CD25+ Tregs and inducing Th1 to Th2 shift in both cells and cytokines. Vaccine 27:690-700